UNICYCIVE THERAPEUTICS, INC. (UNCY) Operating cash flow 2020–2025
UNICYCIVE THERAPEUTICS, INC. (UNCY) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$31.3MFY2025 · since FY2020: -$1.5M → -$31.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$31.3M | -9.6% |
| FY2024 | -$28.6M | -56.3% |
| FY2023 | -$18.3M | -16.8% |
| FY2022 | -$15.7M | -171.4% |
| FY2021 | -$5.8M | -295.3% |
| FY2020 | -$1.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More UNCY financial trends
UNCY RevenueUNCY Net incomeUNCY Net marginUNCY Gross profitUNCY Gross marginUNCY Operating incomeUNCY Operating marginUNCY Free cash flowUNCY Capital expendituresUNCY Return on equityUNCY Stock buybacksUNCY Dividends paidUNCY Total assetsUNCY Total liabilitiesUNCY Shareholders’ equityUNCY overview →